AstraZeneca PLC (AZN) — Cash Flow Reinvestment Rate
AstraZeneca PLC (AZN) has a Cash Flow Reinvestment Rate of 0.28x as of June 2026, reinvesting GBX800.64 Million (capex GBX757.64 Million plus investments GBX43.00 Million) from operating cash flow of GBX2.91 Billion. See how much free cash does AstraZeneca PLC generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (1990–2025)
Historical reinvestment intensity for AstraZeneca PLC across 36 annual periods. For the full cash flow conversion analysis, see how efficiently does AstraZeneca PLC generate cash.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (1990–2025)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. See AZN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | GBX6.00 Billion | GBX14.57 Billion | GBX5.91 Billion | ▼ -61.1% |
| 2024 | 1.06x | GBX12.57 Billion | GBX11.86 Billion | GBX4.59 Billion | ▲ +39.8% |
| 2023 | 0.76x | GBX7.84 Billion | GBX10.35 Billion | GBX3.78 Billion | ▲ +34.4% |
| 2022 | 0.56x | GBX5.53 Billion | GBX9.81 Billion | GBX2.57 Billion | ▲ +19.9% |
| 2021 | 0.47x | GBX2.81 Billion | GBX5.96 Billion | GBX2.20 Billion | ▼ -51.0% |
| 2020 | 0.96x | GBX4.61 Billion | GBX4.80 Billion | GBX2.61 Billion | ▲ +10.2% |
| 2019 | 0.87x | GBX2.58 Billion | GBX2.97 Billion | GBX2.46 Billion | ▲ +50.9% |
| 2018 | 0.58x | GBX1.51 Billion | GBX2.62 Billion | GBX1.37 Billion | ▼ -0.1% |
| 2017 | 0.58x | GBX2.07 Billion | GBX3.58 Billion | GBX1.62 Billion | ▼ -61.9% |
| 2016 | 1.52x | GBX6.28 Billion | GBX4.14 Billion | GBX2.31 Billion | ▲ +64.6% |
| 2015 | 0.92x | GBX3.06 Billion | GBX3.32 Billion | GBX2.79 Billion | ▲ +127.4% |
| 2014 | 0.41x | GBX2.86 Billion | GBX7.06 Billion | GBX2.75 Billion | ▲ +45.7% |
| 2013 | 0.28x | GBX2.06 Billion | GBX7.40 Billion | GBX2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | GBX4.62 Billion | GBX6.95 Billion | GBX4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | GBX1.30 Billion | GBX7.82 Billion | GBX1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | GBX2.42 Billion | GBX10.68 Billion | GBX2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | GBX2.96 Billion | GBX11.74 Billion | GBX2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | GBX4.04 Billion | GBX8.74 Billion | GBX4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | GBX1.68 Billion | GBX7.51 Billion | GBX1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | GBX1.34 Billion | GBX7.69 Billion | GBX1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | GBX979.00 Million | GBX6.74 Billion | GBX979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | GBX332.00 Million | GBX4.87 Billion | GBX332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | GBX1.28 Billion | GBX3.42 Billion | GBX1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | GBX1.34 Billion | GBX4.83 Billion | GBX1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | GBX2.26 Billion | GBX2.71 Billion | GBX2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | GBX1.46 Billion | GBX2.34 Billion | GBX1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | GBX2.75 Billion | GBX908.55 Million | GBX2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | GBX844.88 Million | GBX879.74 Million | GBX844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | GBX755.47 Million | GBX747.21 Million | GBX755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | GBX638.76 Million | GBX787.75 Million | GBX638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | GBX431.11 Million | GBX585.64 Million | GBX431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | GBX492.47 Million | GBX625.36 Million | GBX492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | GBX462.99 Million | GBX705.58 Million | GBX462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | GBX406.47 Million | GBX206.27 Million | GBX406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | GBX385.46 Million | GBX505.22 Million | GBX385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | GBX540.10 Million | GBX806.30 Million | GBX540.10 Million | — |